ExodusPoint Capital Management »

Zentalis Pharmaceuticals shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $364k 75k 4.85
2023-06-30 $519k 18k 28.19
2023-03-31 $1.3M 75k 17.20
2022-12-31 $1.7M 86k 20.14
2022-09-30 $3.4M 158k 21.66
2021-06-30 $282k 5.3k 53.21

More positions owned by ExodusPoint Capital Management

Amazon Put Option (AMZN)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple Put Option (AAPL)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
NVIDIA Corporation Put Option (NVDA)
Topbuild
Penumbra (PEN)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Shopify Cl A Sub Vtg Shs Call Option (SHOP)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Intel Corporation Put Option (INTC)
Select Sector Spdr Tr St Str Finl Etf (XLF)
Microsoft Corporation (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
BlackRock
Two Sigma Investments
Vanguard Capital Management
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Opaleye Management
OrbiMed Advisors
Decheng Capital
Geode Capital Management
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals